Monday, January 7, 2013

• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 7)
• Peregrine shares rise on cancer study reviewAP (Mon, Jan 7)
• The Nasdaq Now: Apple, Amazon Move in Opposite Directions After Analyst Actionat Minyanville (Mon, Jan 7)
• Up 70%, Peregrine's Clinical Lemon Becomes Lemonadeat Motley Fool (Mon, Jan 7)
• Peregrine Pharmaceutical's Big Jumpat Seeking Alpha (Mon, Jan 7)
• Peregrine provides update on the internal review of its Phase II NSCLC trialat theflyonthewall.com (Mon, Jan 7)
• Peregrine Pharmaceuticals Provides Update on the Internal Review of Its Phase II Second-Line Non-Small Cell Lung Cancer TrialMarketwired (Mon, Jan 7)

Friday, January 4, 2013

• 5 Stocks Poised for Breakoutsat TheStreet (Fri, Jan 4)
• Are Short-Sellers Onto Something at Peregrine?at Motley Fool (Fri, Jan 4)
• Biotech Industry Experiencing More FDA New Drug Approvals in 2012Marketwired (Fri, Jan 4)

Friday, December 28, 2012

• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors orEDGAR Online (Fri, Dec 28)

Wednesday, December 26, 2012

• 5 Reasons Not to Worry About Next Yearat Motley Fool (Wed, Dec 26)

Thursday, December 20, 2012

• Why Shares of Oncothyreon Imploded Yesterdayat Motley Fool (Thu, Dec 20)

Wednesday, December 19, 2012

• 3 Stocks That Blew the Market Awayat Motley Fool (Wed, Dec 19)

Saturday, December 15, 2012

• Celgene Investors: What to Watchat Motley Fool (Sat, Dec 15)

Thursday, December 13, 2012

• The Best of 2012 #9: Hemispherx BioPharmaat Motley Fool (Thu, Dec 13)

Wednesday, December 12, 2012

• The Nasdaq Now: Pharma Stocks Peregrine, Acadia Among Top Gainersat Minyanville (Wed, Dec 12)
• Gilead Sciences Okays Stock Split, Peregrine Restored to Nasdaq: Healthcare Biz Wrapat Wall St. Cheat Sheet (Wed, Dec 12)

Tuesday, December 11, 2012

• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Dec 11)
• Peregrine Regains Compliance With NASDAQ Minimum Bid Price Listing RequirementMarketwired (Tue, Dec 11)
• 5 Reasons Not to Worry This Weekat Motley Fool (Tue, Dec 11)
• Peregrine Pharmaceuticals Beats Earnings Estimatesat Seeking Alpha (Tue, Dec 11)

Monday, December 10, 2012

• Peregrine Pharmaceuticals Management Discusses Q2 2013 Results - Earnings Call Transcriptat Seeking Alpha (Mon, Dec 10)
• PEREGRINE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD DiscloEDGAR Online (Mon, Dec 10)
• 4 Stories to Watch This Week in the Health-Care Sectorat Motley Fool (Mon, Dec 10)

Add PPHM News to My Yahoo!